Systemic Sclerosis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Optimised proton pump inhibitor therapy plus a prokinetic agent
The manometric pattern is typical of systemic-sclerosis oesophageal involvement: distal aperistalsis with a hypotensive lower oesophageal sphincter, causing impaired clearance and severe reflux. Current EULAR recommendations support proton pump inhibitors for SSc-related gastro-oesophageal reflux and consideration of a prokinetic for symptomatic dysmotility. PPI treatment should therefore be optimised, commonly by increasing dose or frequency, with an appropriately selected prokinetic. Oesophageal dilation is indicated for a demonstrated mechanical stricture, which endoscopy has excluded. Fundoplication is not first-line and can aggravate dysphagia in severe aperistalsis; surgery is reserved for carefully selected, medically refractory cases. Mycophenolate does not reliably reverse established oesophageal smooth-muscle dysfunction. Nifedipine may further lower lower-oesophageal-sphincter pressure and worsen reflux.
Reference: European Alliance of Associations for Rheumatology, EULAR recommendations for the treatment of systemic sclerosis: 2023 update, gastrointestinal involvement recommendations, published 2025. https://www.eular.org/document/download/1021/cb11a479-9d7a-4b7e-8020-b8cc1dc69bb8/932